Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114014787B details a high-purity asymmetric route for florfenicol intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN104031009B enables high optical purity tetrahydrofuran-2-carboxylic acids via benzylamine resolution. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Discover a novel purification method for Indacaterol intermediates using m-chlorobenzoic acid, offering higher yield and purity for reliable API intermediate supply chains.
Novel resolution method using L-Tyrosine methyl ester achieves >99.5% ee. Cost-effective, scalable process for pharmaceutical intermediates.
Patent CN100473640C details a novel resolution method for trans-2,3-diamino-1,2,3,4-tetrahydronaphthalene using tartaric acid derivatives, offering high ee values and scalable manufacturing.
Novel route for VX-960 intermediate via cyanation and resolution. High purity, mild conditions, cost-effective manufacturing for global supply chains.
Patent CN105820113A details a robust chiral resolution method for Crizotinib intermediates. This process ensures high purity, operational simplicity, and substantial cost reduction in pharmaceutical manufacturing.
Patent CN108137530A details optical resolution for β-2-thienyl-alanine. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN101100428B details an eco-friendly boric acid catalyzed route for high-purity chiral diethyl tartrate, offering significant cost and environmental advantages for pharma supply chains.
Patent CN104058935B details high-purity synthesis route. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN111763150B reveals a novel L-glutamic acid resolution method for high-purity sertraline, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN114436877A details a novel Sacubitril synthesis avoiding high-risk oxidation. Achieve cost reduction in cardiovascular drug manufacturing with scalable routes.
Patent CN113582982B reveals a novel chiral resolution and coupling route for Aprepitant, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN114394907A details a safer, scalable route for norepinephrine bitartrate, offering cost reduction in pharmaceutical manufacturing and reliable supply chain continuity.
Patent CN105420338B reveals lipase fractionation for high-purity L-Valsartan. Enhances supply chain reliability and reduces environmental impact for global pharmaceutical manufacturing.
Patent CN107382697A details efficient chiral resolution for Palonosetron intermediate, ensuring high purity and supply stability for pharmaceutical manufacturing.
Patent CN104263796A details a high-yield chiral synthesis route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Novel resolution process for chiral piperidine intermediates. Reduces steps and cost for pharmaceutical manufacturing. Reliable supply chain partner.
Patent CN100546969C details a cost-effective resolution method for 2-hydroxymethyl-3-phenylpropionic acid using N-Octylglucamine, offering high optical purity for pharmaceutical synthesis.
Patent CN103193779A based eszopiclone preparation method offers high purity and cost reduction for pharmaceutical intermediate manufacturing supply chains.